Follow
Ulus Salih Akarca
Ulus Salih Akarca
Other namesUlus Akarca, Ulus S Akarca
Verified email at ege.edu.tr
Title
Cited by
Cited by
Year
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
20602017
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
HLA Janssen, M van Zonneveld, H Senturk, S Zeuzem, US Akarca, ...
The Lancet 365 (9454), 123-129, 2005
15582005
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
14642018
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
5562014
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
EHCJ Buster, HJ Flink, Y Cakaloglu, K Simon, J Trojan, F Tabak, TMK So, ...
Gastroenterology 135 (2), 459-467, 2008
5112008
Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.
AS Lok, U Akarca, S Greene
Proceedings of the National Academy of Sciences 91 (9), 4077-4081, 1994
5021994
Novel hybridization indicator methylene blue for the electrochemical detection of short DNA sequences related to the hepatitis B virus
A Erdem, K Kerman, B Meric, US Akarca, M Ozsoz
Analytica Chimica Acta 422 (2), 139-149, 2000
4272000
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
YF Liaw, IS Sheen, CM Lee, US Akarca, GV Papatheodoridis, ...
Hepatology 53 (1), 62-72, 2011
4132011
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
4072014
Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study
N Tozun, O Ozdogan, Y Cakaloglu, R Idilman, Z Karasu, U Akarca, ...
Clinical Microbiology and Infection 21 (11), 1020-1026, 2015
3832015
Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels
V Rijckborst, BE Hansen, Y Cakaloglu, P Ferenci, F Tabak, M Akdogan, ...
Hepatology 52 (2), 454-461, 2010
3362010
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
2912022
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
2712014
Electrochemical DNA biosensor for the detection of TT and Hepatitis B virus from PCR amplified real samples by using methylene blue
B Meric, K Kerman, D Ozkan, P Kara, S Erensoy, US Akarca, M Mascini, ...
Talanta 56 (5), 837-846, 2002
2122002
Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos (t) ide-naive patients with chronic hepatitis B
AS Lok, H Trinh, G Carosi, US Akarca, A Gadano, F Habersetzer, ...
Gastroenterology 143 (3), 619-628. e1, 2012
1832012
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
D FitzSimons, G François, A Hall, B McMahon, A Meheus, A Zanetti, ...
Vaccine 23 (32), 4158-4166, 2005
1832005
DNA electrochemical biosensor for the detection of short DNA sequences related to the hepatitis B virus
A Erdem, K Kerman, B Meric, US Akarca, M Ozsoz
Electroanalysis: An International Journal Devoted to Fundamental and …, 1999
1711999
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
H Wedemeyer, C Yurdaydin, S Hardtke, FA Caruntu, MG Curescu, ...
The Lancet infectious diseases 19 (3), 275-286, 2019
1672019
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
Z Omer, S Cetinkalp, M Akyildiz, F Yilmaz, Y Batur, C Yilmaz, U Akarca
European journal of gastroenterology & hepatology 22 (1), 18-23, 2010
1572010
Naturally occurring hepatitis B virus core gene mutations
US Akarca, ASF Lok
Hepatology 22 (1), 50-60, 1995
1471995
The system can't perform the operation now. Try again later.
Articles 1–20